Abstract
There has been an increased interest in the use of therapeutic granulocyte transfusion in recent years because premedication of donors with granulocyte colony stimulating factors produces much higher doses of granulocytes for transfusion. Other factors which influence the outcome of transfusion include the types of infection being treated, the likelihood of recipient marrow recovery and recipient alloimmunization. This review provides a historical perspective on these issues.
Author supplied keywords
Cite
CITATION STYLE
Schiffer, C. A. (2006, September). Granulocyte transfusion therapy 2006: The comeback kid? Medical Mycology. https://doi.org/10.1080/13693780600752499
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.